PBPetr Busek

Petr Busek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Petr Busek has a total of 220 co-authors. Here are the top co-authors by number of shared publications:

  • Aleksi Sedo

    Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic

    26 shared publications
  • Aleksi Šedo

    Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague

    8 shared publications
  • Premysl Fric

    Laboratory of Gastroenterology, Charles University, 121 11 Prague 2

    8 shared publications
  • Martin Laclav

    Department of Medicine/Gastroenterology, Military University Hospital

    7 shared publications
  • Bohuš Bunganič

    Department of Medicine, First Faculty of Medicine, Charles University and Military University Hospital, U Vojenské Nemocnice 1200, 169 02 Prague, Czech Republic

    6 shared publications
  • Eva Balaziova

    Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic

    6 shared publications

Latest Publications

  • Open Access

    FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma

    by Magdalena Houdova Megova, Chloe Shard, Barbora Vymolova, Nikola Ternerova, Tereza Svablova, Tomas Buna, Daniel Straka, Zdislava Vanickova, Evzen Krepela, Helena Kupcova Skalnikova, et al.

    Glioblastoma (GBM) is a highly aggressive primary brain tumor characterized by profound immunosuppression that facilitates tumor progression and promotes therapeutic resistance. Fibroblast activation protein (FAP), a recognized theranostic target in multiple cancers, is upregulated in GBM and predominantly expressed by pericyte-like stromal cells. Here we identify a role for FAP⁺ pericyte-like cells in shaping the GBM immune microenvironment through monocyte recruitment and differentiation. Analysis of The Cancer Genome Atlas (TCGA) datasets, supported by reverse-transcription quantitative PCR and immunohistochemistry, revealed that elevated FAP expression—serving as a proxy for the abundance of FAP⁺ pericyte-like cells—is associated with an immune-enriched tumor microenvironment characterized by higher macrophage abundance and elevated expression of M2 polarization markers. Spatial analyses, including immunofluorescence and spatial transcriptomics, demonstrated that immunosuppressive macrophages preferentially localize in proximity to FAP⁺ pericytes. Single-cell RNA sequencing identified these FAP⁺ cells as a distinct perivascular stromal subset with a unique expression pattern of extracellular matrix components and cytokines, including CCL2 and CSF1, with corresponding receptors expressed on myeloid cells. Functional assays using patient-derived FAP⁺ pericyte-like cells confirmed their ability to attract monocytes via soluble mediators and to promote their differentiation and polarization into tumor-associated macrophages with immunoregulatory features, partly mediated by the CSF1–CSF1R axis. Orthotopic co-implantation experiments in mice further supported their capacity to enhance myeloid infiltration in vivo. Consistent with these biological effects, a transcriptional signature characteristic of FAP⁺ pericytes correlated with worse overall survival in patients with GBM. Together, these findings position FAP⁺ pericyte-like cells as modulators of the GBM immune landscape, fostering a tumor-permissive niche by promoting the differentiation of circulating monocytes into immunoregulatory macrophages. Targeting this stromal population may offer new therapeutic avenues to reprogram tumor-associated immune responses in GBM.

  • Open Access

    PIWIL2 contributes to glioblastoma stem cell phenotypes

    by Elena Garcia-Borja, Rosana Mateu, Frantisek Siegl, Nikola Ternerova, Jakub Cervenka, Helena Kupcova Skalnikova, Aijia Meng, Ashraf Zaman, Joseph Powell, Marek Vecera, et al.

    PIWI proteins, a conserved Argonaute subfamily of proteins that interact with PIWI-interacting RNAs (piRNAs), have been implicated in cancer development. However, their roles in glioblastoma (GBM), particularly in glioblastoma stem cells (GSCs), a therapy-resistant subpopulation of malignant cells that drives tumor progression, remain insufficiently defined. We integrated bulk RNA sequencing, single-nuclei RNA sequencing, and RT-qPCR across large and well-defined GBM cohorts (146 patients) to generate the first comprehensive transcriptomic, tumor-, and cell-state-resolved analysis of PIWIL1–4 expression. PIWIL2 and PIWIL4 were consistently expressed in GBM, whereas PIWIL1 and PIWIL3 were largely absent. Single-nuclei RNA sequencing showed that PIWIL2 was enriched in the mesenchymal-like 2 (MES2) state associated with hypoxia, a condition linked to cancer stemness. Using 24 paired patient-derived GSC and non-GSC cultures, we found that PIWIL2 transcript expression was consistently enriched in GSCs and decreased upon differentiation. Transient siRNA-mediated silencing of PIWIL2 reduced GSC viability and was associated with reduced sphere-forming capacity, decreased total normalized piRNA counts, and altered expression of specific piRNAs. PIWIL4 was expressed in both GSC and non-GSC cultures and was enriched in MES1-, AC-, and NPC2-like states. Together, these findings provide a comprehensive characterization of PIWI family expression in GBM and, through integrated transcriptomic and functional analyses, identify PIWIL2 as the PIWI family member most consistently linked to the GSC phenotype.

  • Open Access

    Brain metastasis‐associated fibroblasts shape the tumour microenvironment to enhance cancer cell invasion

    by Barbora Výmolová, Lucie Pfeiferová, Tadeáš Karel Smetana, Petr Výmola, Nikola Ternerová, Michal Zubaľ, Michal Kolář, Jana Šáchová, Soňa Gyönyörová, Eva Balážiová, et al.

    Brain metastases (BrM) are a frequent and life‐threatening complication of solid tumours, with lung cancer representing their most common source. While cancer‐associated fibroblasts (CAFs) are well‐established contributors to tumour progression in many extracranial malignancies, their presence and function within the brain tumour microenvironment, where fibroblasts have long been considered scarce or absent, remain poorly understood. Here, we isolated and characterised fibroblast‐like cells from 13 human BrMs of diverse origins. These BrM‐associated CAFs (BrM‐CAFs) expressed canonical CAF markers and showed reduced proliferation and increased senescence compared to normal fibroblasts. Their transcriptome was enriched for extracellular matrix (ECM)‐related genes, including multiple collagens, fibronectin, and matrix‐remodelling enzymes. In vitro, BrM‐CAFs produced a fibrillar ECM, and in BrM tissues, their abundance was associated with collagen I and fibronectin deposition. Transcriptomic, proteomic, and secretome analyses further revealed that BrM‐CAFs produce multiple cytokines, chemokines, and growth factors that promote cell motility. BrM‐CAF conditioned medium promoted both monocyte migration and the migration of cancer cells, including established cell lines and patient‐derived lung cancer BrM cells; monocyte migration was partially reduced by inhibition of CCL2/CCR2 signalling, whereas blocking CXCL12, CXCL16, or CX3CL1 attenuated BrM‐CAF‐induced cancer cell migration. Beyond these effects on migration, exposure to BrM‐CAFs increased cancer cell invasion in transwell and heterotypic 3D spheroid assays. In contrast, their effects on cancer cell proliferation were limited and did not indicate a growth‐promoting role. Exposure to BrM‐CAFs was also associated with increased expression of interferon‐stimulated genes in cancer cells. Together, our findings support a role for BrM‐CAFs in shaping the brain metastatic microenvironment through ECM remodelling and the secretion of pro‐migratory mediators, promoting monocyte and cancer cell migration and enhancing cancer cell invasion. These data identify BrM‐CAFs as active stromal participants in BrM biology and support further investigation of their biological, diagnostic, and therapeutic relevance.

  • Open Access

    Differential Expression of P-Element–Induced Wimpy Testis (PIWI)–Interacting RNAs in Glioblastoma Stem Cells Affects Their Biological Features: Implications for Tumor Progression and Patient Survival

    by Frantisek Siegl, Elena Garcia-Borja, Rosana Mateu, Karolina Trachtova, Matej Jasik, Martin Kopecky, Marek Vecera, Lenka Radova, Michal Hendrych, Tomas Kazda, et al.

  • Open Access

    Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA

    by Dora Konečná, Petr Výmola, Nikola Ternerová, Barbora Výmolová, Elena Garcia-Borja, Rosana Mateu, Filip Šroubek, Jan Pankrác, John C. Widen, Matthew Bogyo, et al.

    OBJECTIVE: The highly infiltrative growth of glioblastoma (GBM) makes distinction between the tumor and normal brain tissue challenging. Therefore, fluorescence-guided surgery is often used to improve visual identification of radiological tumor margins. The aim of this study was to evaluate the ability of recently developed molecularly targeted near-infrared (NIR) protease-activated probes to visualize GBM tissue and to compare the most promising candidate with the gold standard, 5-aminolevulinic acid (5-ALA). METHODS: Single-substrate probes 6QC-ICG and 6QC-Cy5 (cysteine cathepsin cleavable), double-substrate probes AG2-FNIR and AG2-Cy5 (cysteine cathepsin and caspase 3 cleavable), and 5-ALA were administered intravenously to mice with orthotopic tumors. Activation of the probes was also evaluated in cell cultures in vitro and in biopsy material from patients with GBM ex vivo. The tumor to normal brain tissue fluorescence ratio (TNR) was quantified in brain sections using preclinical and clinical visualization platforms, and in tissue homogenates and cell suspensions using spectrofluorimetry. Subcellular localization of the fluorophores was visualized by confocal microscopy. RESULTS: In vitro, the single-substrate probe 6QC-ICG was cleaved in glioma cells and macrophages, and the resulting fluorophore accumulated intracellularly. In experimental GBMs, both single- and double-substrate probes visualized tumor tissue, while in healthy brain tissue the signal was minimal. TNR was highest for 6QC-ICG and AG2-FNIR, but the signal intensity was higher for 6QC-ICG. Using xenograft and syngeneic mouse models, as well as human GBM biopsy material ex vivo, the authors confirmed the ability of 6QC-ICG to specifically visualize the glioma tissue using preclinical and clinical visualization platforms. Finally, a comparison with 5-ALA in animals coadministered with both compounds revealed a higher TNR for 6QC-ICG in experimental GBMs. CONCLUSIONS: The cysteine cathepsin–cleavable probe 6QC-ICG is activated by glioma cells and tumor-associated macrophages, leading to a high contrast between tumor and nontumorous brain tissue that is superior to that of the current standard, 5-ALA. In addition to a well-defined mechanism of action, protease-activated probes that use NIR fluorophores (e.g., indocyanine green) have the advantage of low absorption and scattering of the NIR light and lower tissue autofluorescence. These results suggest that 6QC-ICG has the potential to become the targeted agent in intraoperative detection of GBM tissue using fluorescence imaging.


  • Open Access

    Microtubule‐associated NAV3 regulates invasive phenotypes in glioblastoma cells

    by Aneta Škarková, Markéta Pelantová, Ondřej Tolde, Anna Legátová, Rosana Mateu, Petr Bušek, Elena Garcia‐Borja, Aleksi Šedo, Sandrine Etienne‐Manneville, Daniel Rösel, et al.

    Glioblastomas are aggressive brain tumors for which effective therapy is still lacking, resulting in dismal survival rates. These tumors display significant phenotypic plasticity, harboring diverse cell populations ranging from tumor core cells to dispersed, highly invasive cells. Neuron navigator 3 (NAV3), a microtubule‐associated protein affecting microtubule growth and dynamics, is downregulated in various cancers, including glioblastoma, and has thus been considered a tumor suppressor. In this study, we challenge this designation and unveil distinct expression patterns of NAV3 across different invasion phenotypes. Using glioblastoma cell lines and patient‐derived glioma stem‐like cell cultures, we disclose an upregulation of NAV3 in invading glioblastoma cells, contrasting with its lower expression in cells residing in tumor spheroid cores. Furthermore, we establish an association between low and high NAV3 expression and the amoeboid and mesenchymal invasive phenotype, respectively, and demonstrate that overexpression of NAV3 directly stimulates glioblastoma invasive behavior in both 2D and 3D environments. Consistently, we observed increased NAV3 expression in cells migrating along blood vessels in mouse xenografts. Overall, our results shed light on the role of NAV3 in glioblastoma invasion, providing insights into this lethal aspect of glioblastoma behavior.


  • Open Access

    Fibrillar extracellular matrix produced by pericyte‐like cells facilitates glioma cell dissemination

    by Petr Vymola, Elena Garcia‐Borja, Jakub Cervenka, Eva Balaziova, Barbora Vymolova, Jana Veprkova, Petr Vodicka, Helena Skalnikova, Robert Tomas, David Netuka, et al.

    Gliomagenesis induces profound changes in the composition of the extracellular matrix (ECM) of the brain. In this study, we identified a cellular population responsible for the increased deposition of collagen I and fibronectin in glioblastoma. Elevated levels of the fibrillar proteins collagen I and fibronectin were associated with the expression of fibroblast activation protein (FAP), which is predominantly found in pericyte‐like cells in glioblastoma. FAP+ pericyte‐like cells were present in regions rich in collagen I and fibronectin in biopsy material and produced substantially more collagen I and fibronectin in vitro compared to other cell types found in the GBM microenvironment. Using mass spectrometry, we demonstrated that 3D matrices produced by FAP+ pericyte‐like cells are rich in collagen I and fibronectin and contain several basement membrane proteins. This expression pattern differed markedly from glioma cells. Finally, we have shown that ECM produced by FAP+ pericyte‐like cells enhances the migration of glioma cells including glioma stem‐like cells, promotes their adhesion, and activates focal adhesion kinase (FAK) signaling. Taken together, our findings establish FAP+ pericyte‐like cells as crucial producers of a complex ECM rich in collagen I and fibronectin, facilitating the dissemination of glioma cells through FAK activation.


  • Open Access

    Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells

    by Elena Garcia-Borja, Frantisek Siegl, Rosana Mateu, Ondrej Slaby, Aleksi Sedo, Petr Busek, Jiri Sana

    Small noncoding RNAs play an important role in various disease states, including cancer. PIWI proteins, a subfamily of Argonaute proteins, and PIWI-interacting RNAs (piRNAs) were originally described as germline-specific molecules that inhibit the deleterious activity of transposable elements. However, several studies have suggested a role for the piRNA-PIWI axis in somatic cells, including somatic stem cells. Dysregulated expression of piRNAs and PIWI proteins in human tumors implies that, analogously to their roles in undifferentiated cells under physiological conditions, these molecules may be important for cancer stem cells and thus contribute to cancer progression. We provide an overview of piRNA biogenesis and critically review the evidence for the role of piRNA-PIWI axis in cancer stem cells. In addition, we examine the potential of piRNAs and PIWI proteins to become biomarkers in cancer.


  • Open Access

    Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination

    by Petr Vymola, Elena Garcia Borja, Jakub Cervenka, Eva Balaziova, Barbora Vymolova, Jana Veprkova, Petr Vodicka, Helena Skalnikova, Robert Tomas, David Netuka, et al.

    Purpose Gliomagenesis is associated with changes in extracellular matrix (ECM) composition. We investigate the role of fibroblast activation protein-positive (FAP+) pericyte-like cells in ECM alterations in glioblastoma and their impact on glioma cells. Methods Bioinformatic analysis, immunohistochemistry, and ELISA were used to evaluate the expression of ECM proteins and FAP. FAP + pericyte-like cells were isolated from human glioblastomas, ECM production was quantified by ELISA and using mass spectrometry analysis of 3D matrices. Haptotaxis and focal adhesion kinase (FAK) signaling activation assays were performed to assess the influence of the ECM on glioma cells. Results Higher FAP expression was associated with elevated levels of collagen I and fibronectin in glioblastoma. FAP + pericyte-like cells were present in regions rich in collagen I and fibronectin in biopsy material and produced substantially more collagen I and fibronectin in vitro compared to other cell types found in glioblastoma. Mass spectrometry revealed that in contrast to glioma cells, 3D matrices produced by FAP + pericyte-like cells were rich in collagen I and fibronectin and contained several key basement membrane proteins. ECM produced by FAP + pericyte-like cells enhanced migration and adhesion of glioma cells, including glioma stem-like cells, and promoted focal adhesion kinase (FAK) signaling. Conclusion This study establishes FAP + pericyte-like cells as crucial producers of an ECM rich in collagen I and fibronectin in glioblastoma microenvironment. Such ECM triggers FAK activation and facilitates the dissemination of glioma cells. Our data provide new insights into the mechanisms underlying gliomagenesis.

  • Open Access

    Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours

    by Michal Zubaľ, Barbora Výmolová, Ivana Matrasová, Petr Výmola, Jana Vepřková, Martin Syrůček, Robert Tomáš, Zdislava Vaníčková, Evžen Křepela, Dora Konečná, et al.